PMID: 66569Apr 9, 1977

Effect of granulocytic chalone on acute myeloid leukaemia in man. A follow-up study

Lancet
J A VilpoW A Jones

Abstract

Non-pyrogenic preparations of granulocytic chalone have been administered to patient with acute myeloid leukaemia (A.M.L.) who had relapsed after chalone-induced complete remission of the disease. Another regression of the leukaemia was obtained. Normal and leukaemic granulocytes were inhibited without effect on other cell types. Survival was prolonged in 4 other patients with A.M.L. Further investigations are needed to elucidate the therapeutic role of granulocytic chalone.

References

Jun 7, 1969·Nature·T Rytömaa, K Kiviniemi

Citations

Nov 1, 1982·Biulleten' eksperimental'noĭ biologii i meditsiny·P D GodorozhaG B Pliss
Mar 1, 1979·Mechanisms of Ageing and Development·J C Houck
Mar 1, 1979·Mechanisms of Ageing and Development·T Rytömaa, H Toivonen
Jan 1, 1982·Pharmacology & Therapeutics·A M AttallahJ C Petricciani
Jan 18, 1979·Nature·M J Cline, D W Golde
Sep 1, 1981·Biulleten' eksperimental'noĭ biologii i meditsiny·P D GodorozhaG B Pliss
Dec 12, 2017·Cell Proliferation·T Rytömaa, K Grip-Rytömaa

Related Concepts

Alkaline Phosphatase
SGOT - Glutamate oxaloacetate transaminase
Blood Platelets
Erythrocyte Sedimentation Rate Result
Marrow
Bone Marrow Cells
Drug Evaluation
Granulocyte
Growth Inhibitors
Eryhem

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.